Corient Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Corient Capital Partners’s Portfolio BMRN Stock Details BMRN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$259K	Hold
2022 Q2	$259K	Buy
2022 Q1	$200K	Sell
2021 Q4	$239K	Sell
2021 Q3	$218K	Buy
2021 Q2	$218K	Buy
2021 Q1	–	Sell
2020 Q4	$201K	Buy
2020 Q3	–	Sell
2020 Q2	$1.23M	Buy
2020 Q1	$680K	Buy